The 13th R. Geigy Award 2024 goes to West Africa. Scientists from the Centre Suisse de Recherches Scientifiques en Côte d'Ivoire (CSRS) are being honored with the award, which is endowed with CHF 20,000.

The Chronic Diseases Clinic of Ifakara (CDCI) is celebrating its 20th anniversary, marking two decades of providing healthcare, health training and clinical research in rural Tanzania. Established through a collaboration between Swiss and Tanzanian institutions to support individuals living with HIV/AIDS, CDCI has evolved into a leading model for HIV care in rural Africa. To honour this milestone, the clinic hosted a two-day event focused on HIV/AIDS and non-communicable diseases (NCDs).

To estimate the efficacy of antimalarial drugs, distinguishing recurring from new infections is crucial. Researchers from Swiss TPH have now compared five genotyping methods to make this distinction and assessed their impact on drug efficacy. The results, published yesterday in the peer-reviewed journal The Lancet Microbe, could help confirm antimalarial resistance and inform WHO guidelines.

As the autumn semester begins, Swiss TPH warmly welcomes the new students enrolled in our bachelor's, master's, and PhD programmes. 58 new master's and PhD students from various countries have officially started their academic journey with us today. We also like to warmly welcome everyone joining our postgraduate courses.

More than half of the global population is estimated to lack safe drinking water services in a study published yesterday in the journal Science. The results are depicted in a map that researchers compiled using machine learning based on data from household surveys and data derived from earth observations. The study was led by the Swiss Federal Institute of Aquatic Science and Technology (Eawag) and supported by Swiss TPH, WHO, UNICEF and ETH Zurich.

Swiss TPH researchers and partners published a report that shows children born in 2020 in Europe will experience four times more extreme events, especially heatwaves, due to climate change. The systematic review, conducted on behalf of the European Environment Agency, underscores the urgent need for child-focused health measures.

Maintaining physical activity throughout life is crucial for health and well-being. However, the age-related decline in average physical activity is a challenge.

Today, on 20 September 2024, the Swiss Tropical and Public Health Institute (Swiss TPH) organised a symposium entitled "Defining the noma research agenda" in Allschwil near Basel.

A study by Swiss TPH and partners has shown that a new, locally adapted mental health intervention for women with young children in Zambia led to a 50% reduction in mental health symptoms.

Researchers at Swiss TPH have demonstrated that the novel drug candidate, emodepside, is highly effective in treating parasitic worm infections in humans, particularly hookworms. The results of a Phase 2b trial, published today in The Lancet, confirmed the drug's strong efficacy and safety profile, building on the promising outcomes of an earlier Phase 2a study. Swiss TPH is collaborating with Bayer to further develop emodepside.